keyword
https://read.qxmd.com/read/38682090/efficacy-and-safety-of-lurasidone-for-schizophrenia-a-systematic-review-and-meta%C3%A2-analysis-of-eight-short%C3%A2-term-randomized-double%C3%A2-blind-placebo%C3%A2-controlled-clinical-trials
#1
JOURNAL ARTICLE
Shan Gao, Ling Fan, Zhigang Yu, Xingxing Xie
Lurasidone is an atypical anti-psychotic approved by the US Food and Drug Administration. It is mainly used to treat schizophrenia in adults through its antagonistic action on dopamine and 5-hydroxytryptamine receptors. The present study systematically assessed the efficacy and safety of lurasidone in the treatment of schizophrenia. Clinical, double-blind, parallel, randomized controlled trials (RCTs) of lurasidone in the treatment of schizophrenia were retrieved from PubMed\Medline, EBSCO, Embase, Cochrane Library, OVID, Web of Science and related clinical trial registration websites up to May 2023...
June 2024: Biomedical Reports
https://read.qxmd.com/read/38666818/modular-hub-genes-in-dna-microarray-suggest-potential-signaling-pathway-interconnectivity-in-various-glioma-grades
#2
JOURNAL ARTICLE
Marco A Orda, Peter Matthew Paul T Fowler, Lemmuel L Tayo
Gliomas have displayed significant challenges in oncology due to their high degree of invasiveness, recurrence, and resistance to treatment strategies. In this work, the key hub genes mainly associated with different grades of glioma, which were represented by pilocytic astrocytoma (PA), oligodendroglioma (OG), anaplastic astrocytoma (AA), and glioblastoma multiforme (GBM), were identified through weighted gene co-expression network analysis (WGCNA) of microarray datasets retrieved from the Gene Expression Omnibus (GEO) database...
March 23, 2024: Biology
https://read.qxmd.com/read/38661668/sex-similarities-and-dopaminergic-differences-in-interval-timing
#3
JOURNAL ARTICLE
Hannah R Stutt, Matthew A Weber, Rachel C Cole, Alexandra S Bova, Xin Ding, Madison S McMurrin, Nandakumar S Narayanan
Rodent behavioral studies have largely focused on male animals, which has limited the generalizability and conclusions of neuroscience research. Working with humans and rodents, we studied sex effects during interval timing that requires participants to estimate an interval of several seconds by making motor responses. Interval timing requires attention to the passage of time and working memory for temporal rules. We found no differences between human females and males in interval timing response times (timing accuracy) or the coefficient of variance of response times (timing precision)...
April 2024: Behavioral Neuroscience
https://read.qxmd.com/read/38658737/dopamine-d1-receptor-in-medial-prefrontal-cortex-mediates-the-effects-of-taar1-activation-on-chronic-stress-induced-cognitive-and-social-deficits
#4
JOURNAL ARTICLE
Meng Sun, Yue Zhang, Xian-Qiang Zhang, Yanan Zhang, Xiao-Dong Wang, Ji-Tao Li, Tian-Mei Si, Yun-Ai Su
Trace amine-associated receptor 1 (TAAR1) is an intracellular expressed G-protein-coupled receptor that is widely expressed in major dopaminergic areas and plays a crucial role in modulation of central dopaminergic neurotransmission and function. Pharmacological studies have clarified the roles of dopamine D1 receptor (D1R) in the medial prefrontal cortex (mPFC) in cognitive function and social behaviors, and chronic stress can inhibit D1R expression due to its susceptibility. Recently, we identified TAAR1 in the mPFC as a potential target for treating chronic stress-induced cognitive and social dysfunction, but whether D1R is involved in mediating the effects of TAAR1 agonist remains unclear...
April 24, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38655111/-in-vitro-characterization-of-125-i-hy-3-24-a-selective-ligand-for-the-dopamine-d3-receptor
#5
JOURNAL ARTICLE
Ji Youn Lee, Ho Young Kim, Paul Martorano, Aladdin Riad, Michelle Taylor, Robert R Luedtke, Robert H Mach
INTRODUCTION: Dopamine D3 receptor (D3R) ligands have been studied for the possible treatment of neurological and neuropsychiatric disorders. However, selective D3R radioligands for in vitro binding studies have been challenging to identify due to the high structural similarity between the D2R and D3R. In a prior study, we reported a new conformationally-flexible benzamide scaffold having a high affinity for D3R and excellent selectivity vs. D2R. In the current study, we characterized the in vitro binding properties of a new radioiodinated ligand, [125 I]HY-3-24...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38653551/beyond-dopamine-novel-strategies-for-schizophrenia-treatment
#6
REVIEW
Paulina Dudzik, Klaudia Lustyk, Karolina Pytka
Despite extensive research efforts aimed at discovering novel antipsychotic compounds, a satisfactory pharmacological strategy for schizophrenia treatment remains elusive. All the currently available drugs act by modulating dopaminergic neurotransmission, leading to insufficient management of the negative and cognitive symptoms of the disorder. Due to these challenges, several attempts have been made to design agents with innovative, non-dopaminergic mechanisms of action. Consequently, a number of promising compounds are currently progressing through phases 2 and 3 of clinical trials...
April 23, 2024: Medicinal Research Reviews
https://read.qxmd.com/read/38651025/maternal-substance-use-and-early-life-adversity-inducing-drug-dependence-in-offspring-interactions-mechanisms-and-treatments
#7
REVIEW
Maysam Fadaei-Kenarsary, Khadijeh Esmaeilpour, Mohammad Shabani, Vahid Sheibani
The likelihood of substance dependency in offspring is increased in cases when there is a family history of drug or alcohol use. Mothering is limited by maternal addiction because of the separation. Maternal separation (MS) leads to the development of behavioural and neuropsychiatric issues in the future. Despite the importance of this issue, empirical investigations of the influences of maternal substance use and separation on substance use problems in offspring are limited, and studies that consider both effects are rare...
February 2024: Addiction & Health
https://read.qxmd.com/read/38649035/synergistic-action-of-vitamin-d3-and-a-on-motor-activity-regulation-in-mice-model-of-extrapyramidal-syndrome-correlational-insights-into-astrocyte-regulation-cytokine-modulation-and-dopaminergic-activity
#8
JOURNAL ARTICLE
Mujittapha U Sirajo, Yahya K Maigari, Abdulrashid Sunusi, Adam N Jibril, Isa Usman Lawal, Badamasi M Ibrahim
BACKGROUND: Extrapyramidal syndromes (EPS) represent neurological side effects of antipsychotic medications, characterized by motor disturbances. While previous studies have indicated the neuroprotective effects of vitamin D and A against EPS, the underlying mechanisms of this protection remain unclear. METHODS: Twenty-four adult mice were categorized into four groups: positive and negative control groups, one receiving a dopamine antagonist, and the other receiving both a dopamine antagonist and vitamins D and A...
April 20, 2024: Journal of Chemical Neuroanatomy
https://read.qxmd.com/read/38644789/naloxone-increases-conditioned-fear-responses-during-social-buffering-in-male-rats
#9
JOURNAL ARTICLE
Takumi Yamasaki, Yasushi Kiyokawa, Arisa Munetomo, Yukari Takeuchi
Social buffering is the phenomenon in which the presence of an affiliative conspecific mitigates stress responses. We previously demonstrated that social buffering completely ameliorates conditioned fear responses in rats. However, the neuromodulators involved in social buffering are poorly understood. Given that opioids, dopamine, oxytocin and vasopressin play an important role in affiliative behaviour, here, we assessed the effects of the most well-known antagonists, naloxone (opioid receptor antagonist), haloperidol (dopamine D2 receptor antagonist), atosiban (oxytocin receptor antagonist) and SR49059 (vasopressin V1a receptor antagonist), on social buffering...
April 22, 2024: European Journal of Neuroscience
https://read.qxmd.com/read/38644533/transient-receptor-potential-ankyrin-1-channel-modulates-the-abuse-related-mechanisms-of-methamphetamine-through-interaction-with-dopamine-transporter
#10
JOURNAL ARTICLE
Kwang-Hyun Hur, Youyoung Lee, Audrey Lynn Donio, Seon-Kyung Kim, Bo-Ram Lee, Jee-Yeon Seo, Dooti Kundu, Kyeong-Man Kim, Stephen J Kohut, Seok-Yong Lee, Choon-Gon Jang
BACKGROUND AND PURPOSE: Methamphetamine (METH) use disorder has risen dramatically over the past decade, and there are currently no FDA-approved medications due, in part, to gaps in our understanding of the pharmacological mechanisms related to METH action in the brain. EXPERIMENTAL APPROACH: Here, we investigated whether transient receptor potential ankyrin 1 (TRPA1) mediates each of several METH abuse-related behaviours in rodents: self-administration, drug-primed reinstatement, acquisition of conditioned place preference, and hyperlocomotion...
April 21, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38642503/conjugation-of-sulpiride-with-a-cell-penetrating-peptide-to-augment-the-antidepressant-efficacy-and-reduce-serum-prolactin-levels
#11
JOURNAL ARTICLE
Yuan Liang, Yu Yang, Ruiyan Huang, Jiangyue Ning, Xingyan Bao, Zelong Yan, Haotian Chen, Li Ding, Chang Shu
Depression ranks as the fourth most prevalent global disease, with suicide incidents occurring at a younger age. Sulpiride (SUL), an atypical antidepressant drug acting as a dopamine D2 receptor antagonist and possessing anti-inflammatory properties, exhibits limited ability to penetrate the blood brain barrier (BBB). This weak penetration hampers its inhibitory effect on prolactin release in the pituitary gland, consequently leading to hyperprolactinemia. In order to enhance the central nervous system efficacy of sulpiride and reduce serum prolactin levels, we covalently linked sulpiride to VPALR derived from the nuclear DNA repair protein ku70...
April 19, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38639539/dopaminergic-modulation-and-computational-admet-insights-for-the-antidepressant-like-effect-of-n-3-phenylselanyl-prop-2-yn-1-yl-benzamide
#12
JOURNAL ARTICLE
Evelyn Mianes Besckow, Kauane Nayara Bahr Ledebuhr, Camila Simões Pires, Marcia Juciele da Rocha, Natália Emanuele Biolosor Kuntz, Benhur Godoi, Cristiani Folharini Bortolatto, César Augusto Brüning
The compound N -(3-(phenylselanyl)prop-2-yn-1-yl)benzamide (SePB), which combines a selenium atom and a benzamide nucleus in an organic structure, has demonstrated a fast antidepressant-like effect in mice. This action is influenced by the serotonergic system and represents a promising development in the search for novel antidepressant drugs to treat major depressive disorder (MDD), which often resists conventional treatments. This study aimed to further explore the mechanism underlying the antidepressant-like effect of SePB by investigating the involvement of the dopaminergic and noradrenergic systems in the tail suspension test (TST) in mice and evaluating its pharmacokinetic profile in silico...
April 19, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38635745/dopamine-d2-receptor-antagonist-counteracts-hyperglycemia-and-insulin-resistance-in-diet-induced-obese-male-mice
#13
JOURNAL ARTICLE
Dina I Vázquez-Carrillo, Ana Luisa Ocampo-Ruiz, Arelí Báez-Meza, Gabriela Ramírez-Hernández, Elva Adán-Castro, José Fernando García-Rodrigo, José Luis Dena-Beltrán, Ericka A de Los Ríos, Magdalena Karina Sánchez-Martínez, María Georgina Ortiz, Gonzalo Martínez de la Escalera, Carmen Clapp, Yazmín Macotela
Obesity leads to insulin resistance (IR) and type 2 diabetes. In humans, low levels of the hormone prolactin (PRL) correlate with IR, adipose tissue (AT) dysfunction, and increased prevalence of T2D. In obese rats, PRL treatment promotes insulin sensitivity and reduces visceral AT adipocyte hypertrophy. Here, we tested whether elevating PRL levels with the prokinetic and antipsychotic drug sulpiride, an antagonist of dopamine D2 receptors, improves metabolism in high fat diet (HFD)-induced obese male mice. Sulpiride treatment (30 days) reduced hyperglycemia, IR, and the serum and pancreatic levels of triglycerides in obese mice, reduced visceral and subcutaneous AT adipocyte hypertrophy, normalized markers of visceral AT function (PRL receptor, Glut4, insulin receptor and Hif-1α), and increased glycogen stores in skeletal muscle...
2024: PloS One
https://read.qxmd.com/read/38629943/current-and-emerging-pharmacotherapy-for-the-treatment-of-gastroparesis
#14
REVIEW
M Ammar Kalas, Irene Sarosiek, Richard W McCallum
INTRODUCTION: Gastroparesis is a chronic disorder characterized by decreased gastric emptying and presents with nausea, vomiting, and abdominal pain which impacts patients' quality of life greatly. The treatment modalities available for gastroparesis have been expanding over the past 2 decades. Currently there are multiple options available for gastroparesis albeit with only one FDA approved medication until June of 2021. AREAS COVERED: We review the different treatments available for gastroparesis and discuss the recently FDA approved intranasal formulation of metoclopramide...
April 17, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38627136/commonly-used-antiemetics-for-prophylaxis-of-postoperative-nausea-and-vomiting-after-caesarean-delivery-with-neuraxial-morphine-a-network-meta-analysis
#15
REVIEW
Lizhong Wang, Jiayue Huang, Huijing Hu, Xiangyang Chang, Feng Xia
BACKGROUND: Dopamine antagonists, 5-HT3 antagonists, and dexamethasone are frequently used in obstetrics to prevent postoperative nausea and vomiting (PONV). However, the superiority of any drug class is yet to be established. This network meta-analysis aimed to compare the efficacy of these antiemetics for PONV prophylaxis in women receiving neuraxial morphine for Caesarean delivery. METHODS: We searched PubMed, Embase, CENTRAL, Web of Science, and Wanfang Data for eligible randomised controlled trials...
April 15, 2024: British Journal of Anaesthesia
https://read.qxmd.com/read/38626644/can-sympathetic-induction-be-a-convenient-technique-for-breeding-amblypharyngodon-mola-hamilton-1822
#16
JOURNAL ARTICLE
Sanayaima Singha, Shivendra Kumar, Kalpajit Gogoi, Pabitra Kumar Saharia, Rajdeep Dutta, Arnab Narayan Patowary, Sangipran Baishya, Kaustubh Bhagawati, Biswajyoti Bordoloi, Dipak Kumar Sarma
Mola carplet (Amblypharyngodon mola) is one of the most popular small fish species of the Indian subcontinent. There are limited studies on captive breeding of this species, which is important for aquaculture and the conservation prospects of this species. The conventional induced breeding method using an inducing agent (GnRHa and dopamine antagonist) is one of the most effective and prevalent methods of breeding fish. It is a laborious and time-consuming process, particularly in mass fish breeding and in lieu of that, a less time-consuming method - sympathetic induction of the broodstock, is used in some regions of India, particularly in big carp fish...
April 15, 2024: Animal Reproduction Science
https://read.qxmd.com/read/38623339/a-dopamine-d1-like-receptor-specific-agonist-improves-the-survival-of-septic-mice
#17
JOURNAL ARTICLE
Koichi Tanaka, Mohammed E Choudhury, Satoshi Kikuchi, Ikuko Takeda, Kensuke Umakoshi, Noriyuki Miyaue, Kanta Mikami, Ayane Takenaga, Harumichi Yagi, Rintaro Shinabe, Hironori Matsumoto, Hajime Yano, Masahiro Nagai, Jun Takeba, Junya Tanaka
In this study, a murine sepsis model was developed using the cecum ligation and puncture (CLP) technique. The expression of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) in the brain increased 6 h after CLP but decreased 24 h later when elevated endogenous dopamine levels in the brain were sustained. Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride reduced dopamine levels in the striatum and increased mortality in septic mice...
April 19, 2024: IScience
https://read.qxmd.com/read/38616770/striatal-parvalbumin-interneurons-not-cholinergic-interneurons-are-activated-in-a-mouse-model-of-cerebellar-dystonia
#18
JOURNAL ARTICLE
Taku Matsuda, Ryoma Morigaki, Hiroaki Hayasawa, Hiroshi Koyama, Teruo Oda, Kazuhisa Miyake, Yasushi Takagi
Dystonia is supposed to arise from abnormalities in the motor loop of the basal ganglia; however, there is an ongoing debate regarding cerebellar involvement. We adopted the established cerebellar dystonia mice model by injecting ouabain to examine the contribution of the cerebellum. Initially, we examined whether the entopeduncular nucleus (EPN), substantia nigra pars reticulata (SNr), globus pallidus externus (GPe), and striatal neurons were activated in the model. Next, we examined whether dopamine D1 receptor agonists (D1 agonist) and dopamine D2 receptor antagonists (D2 antagonist) or selective ablation of striatal parvalbumin (PV) interneurons could modulate their involuntary movements...
April 15, 2024: Disease Models & Mechanisms
https://read.qxmd.com/read/38613458/catharanthine-modulates-mesolimbic-dopamine-transmission-and-nicotine-psychomotor-effects-via-inhibition-of-%C3%AE-6-nicotinic-receptors-and-dopamine-transporters
#19
JOURNAL ARTICLE
Benjamin M Williams, Nathan D Steed, Joel T Woolley, Aubrey A Moedl, Christina A Nelson, Gavin C Jones, Matthew D Burris, Hugo R Arias, Oc-Hee Kim, Eun Young Jang, Arik J Hone, J Michael McIntosh, Jordan T Yorgason, Scott C Steffensen
Iboga alkaloids, also known as coronaridine congeners, have shown promise in the treatment of alcohol and opioid use disorders. The objective of this study was to evaluate the effects of catharanthine and 18-methoxycoronaridine (18-MC) on dopamine (DA) transmission and cholinergic interneurons in the mesolimbic DA system, nicotine-induced locomotor activity, and nicotine-taking behavior. Utilizing ex vivo fast-scan cyclic voltammetry (FSCV) in the nucleus accumbens core of male mice, we found that catharanthine or 18-MC differentially inhibited evoked DA release...
April 13, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38605179/the-classical-d1-dopamine-receptor-antagonist-sch23390-is-a-functional-sigma-1-receptor-allosteric-modulator
#20
JOURNAL ARTICLE
Gu-Fang Zhang, Kai-Lian Zhu, Qi Li, Yue Zhang, John L Waddington, Xiang-Dong Du, Xue-Chu Zhen
SCH23390 is a widely used D1 dopamine receptor (D1 R) antagonist that also elicits some D1 R-independent effects. We previously found that the benzazepine, SKF83959, an analog of SCH23390, produces positive allosteric modulation of the Sigma-1 receptor (Sig1R). SCH23390 does not bind to the orthodoxic site of Sig1R but enhances the binding of 3 H (+)-pentazocine to Sig1R. In this study, we investigated whether SCH23390 functions as an allosteric modulator of Sig1R. We detected increased Sig1R dissociation from binding immunoglobulin protein (BiP) and translocation of Sig1R to the plasma membrane in response to SCH23390 in transfected HEK293T and SH-SY5Y cells, respectively...
April 11, 2024: Acta Pharmacologica Sinica
keyword
keyword
64143
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.